• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
NOX

NOXOPHARM LIMITED - Announcements

11.9% ! 9.4¢
Market Cap $25.80M  !
Healthcare Biotechnology
Add to My Watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements



Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
NOX St Vincent's Hospital study passes first milestonePRICE SENSITIVE17/04/18
NOX Notice of Extraordinary General Meeting / Proxy Form09/04/18
NOX Change in substantial holding06/04/18
NOX Change in substantial holding06/04/18
NOX DARRT-1 Clinical Study commencesPRICE SENSITIVE05/04/18
NOX NOX Mid-Year Briefings05/04/18
NOX Section 708 Certificate29/03/18
NOX Appendix 3B29/03/18
NOX NOX raises $10.8 M to advance clinical programPRICE SENSITIVE23/03/18
NOX Trading HaltPRICE SENSITIVE21/03/18
NOX Evidence of Abscopal Responses in PatientsPRICE SENSITIVE21/03/18
NOX Corporate Presentation - Post Interim Clinical Data Release12/03/18
NOX FNN Interview with Noxopharm CEO09/03/18
NOX NOX Reports NOX66 Clinical DataPRICE SENSITIVE06/03/18
NOX Trading HaltPRICE SENSITIVE05/03/18
NOX Appendix 4D and Half Year AccountsPRICE SENSITIVE23/02/18
NOX St Vincent's Hospital study passes first milestone
17/04/18PRICE SENSITIVE
NOX Notice of Extraordinary General Meeting / Proxy Form
09/04/18
NOX Change in substantial holding
06/04/18
NOX Change in substantial holding
06/04/18
NOX DARRT-1 Clinical Study commences
05/04/18PRICE SENSITIVE
NOX NOX Mid-Year Briefings
05/04/18
NOX Section 708 Certificate
29/03/18
NOX Appendix 3B
29/03/18
NOX NOX raises $10.8 M to advance clinical program
23/03/18PRICE SENSITIVE
NOX Trading Halt
21/03/18PRICE SENSITIVE
NOX Evidence of Abscopal Responses in Patients
21/03/18PRICE SENSITIVE
NOX Corporate Presentation - Post Interim Clinical Data Release
12/03/18
NOX FNN Interview with Noxopharm CEO
09/03/18
NOX NOX Reports NOX66 Clinical Data
06/03/18PRICE SENSITIVE
NOX Trading Halt
05/03/18PRICE SENSITIVE
NOX Appendix 4D and Half Year Accounts
23/02/18PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
9.4¢ 		Change
0.010(11.9%) 		Mkt cap ! $25.80M
Open High Low Volume
9.0¢ 9.4¢ 9.0¢ 148.5K

Buyers (Bids)

Vol. Price($)
2800 8.5¢
 

Sellers (Offers)

Price($) Vol.
9.4¢ 32656
Last trade - 14.12pm 21/08/2026 (20 minute delay) ?
NOX (ASX) Chart

Top Stories

Noble Helium expanding portfolio with move to acquire Earth Source Hydrogen

Noble Helium has entered into a binding agreement to acquire 100% of the issued share capital of Earth Source Hydrogen.
Inghams profit slumps as rising costs put chicken prices and margins under pressure Inghams reports a sharp FY26 profit decline as labour, feed and other costs weigh on earnings, while chicken prices face further pressure.
Eastern Gas Corporation jumps on strong gas shows at Macalister Eastern Gas Corporation has obtained positive gas hits from drilling of the Venus-2H horizontal appraisal well at project Venus in Queensland
Janison Education Group secures landmark UK contract with NFER Janison Education Group has been named as principal technology subcontractor under a major Scottish government contract.
Pro Medicus signs $25M contract with US-based Valley Health Pro Medicus' US subsidiary Visage Imaging has signed a seven-year, $25 million contract with Valley Health based in Winchester, Virginia.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.